Paper3729367
In vitro evaluation of various antifungal agents alone and in combination by using an automatic turbidimetric system combined with viable count determinations.
Van der Auwera P and 3 others. Antimicrob Agents Chemother, 1986. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. In vitro evaluation of various antifungal agents alone and in combination by using an automatic turbidimetric system combined with viable count determinations. Papers, record 3729367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3729367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In vitro evaluation of various antifungal agents alone and in combination by using an automatic turbidimetric system combined with viable count determinations.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antifungal Agents | Major topic |
| Amphotericin B | |
| Drug Interactions | |
| Flucytosine | |
| Ketoconazole | |
| Microbial Sensitivity Tests | |
| Nephelometry and Turbidimetry |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5672740 | Treatment of disseminated mycotic infectioons. A new approach to amphotericin B therapy. | Am J Med | 1968 | https://conductscience.org/library/papers/5672740 | PubMed |
| 2 | 3517051 | Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B. | J Clin Microbiol | 1986 | https://conductscience.org/library/papers/3517051 | PubMed |
| 3 | 5118468 | Synergistic action of amphotericin B and 5-fluorocytosine against yeast-like organisms. | Proc Soc Exp Biol Med | 1971 | https://conductscience.org/library/papers/5118468 | PubMed |
| 4 | 4550505 | Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism). | Proc Natl Acad Sci U S A | 1972 | https://conductscience.org/library/papers/4550505 | PubMed |
| 5 | 5054147 | Amphotericin B potentiation of rifampicin as an antifungal agent against the yeast phase of Histoplasma capsulatum. | Science | 1972 | https://conductscience.org/library/papers/5054147 | PubMed |
| 6 | 1090685 | Combined activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans in vitro and in vivo in mice. | J Infect Dis | 1975 | https://conductscience.org/library/papers/1090685 | PubMed |
| 7 | 984806 | Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/984806 | PubMed |
| 8 | 646347 | Turbidimetric studies of growth inhibition of yeasts with three drugs: inquiry into inoculum-dependent susceptibility testing, time of onset of drug effect, and implications for current and newer methods. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/646347 | PubMed |
| 9 | 6993624 | Disappearance of nystatin resistance in Candida mediated by ergosterol. | J Gen Microbiol | 1980 | https://conductscience.org/library/papers/6993624 | PubMed |
| 10 | 6993625 | Inhibition of sterol biosynthesis in Candida albicans by imidazole-containing antifungals. | J Gen Microbiol | 1980 | https://conductscience.org/library/papers/6993625 | PubMed |
| 11 | 6250469 | In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesis. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6250469 | PubMed |
| 12 | 7247356 | Experimental intraabdominal candidiasis in rabbits: therapy with low-total-dose intravenous amphotericin B. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/7247356 | PubMed |
| 13 | 7055395 | Candida infections in surgical patients. Dose requirements and toxicity of amphotericin B. | Ann Surg | 1982 | https://conductscience.org/library/papers/7055395 | PubMed |
| 14 | 7038330 | Chemotherapy of the systemic mycoses. | Med Clin North Am | 1982 | https://conductscience.org/library/papers/7038330 | PubMed |
| 15 | 6295266 | Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6295266 | PubMed |
| 16 | 6343524 | Correlation of in vitro susceptibility test results with in vivo response: flucytosine therapy in a systemic candidiasis model. | J Infect Dis | 1983 | https://conductscience.org/library/papers/6343524 | PubMed |
| 17 | 6356283 | Antifungal action of rifampin. | Rev Infect Dis | 1983 | https://conductscience.org/library/papers/6356283 | PubMed |
| 18 | 6356284 | Interaction of rifampin with other antifungal agents in experimental murine candidiasis. | Rev Infect Dis | 1983 | https://conductscience.org/library/papers/6356284 | PubMed |
| 19 | 6356285 | Combination antifungal chemotherapy for experimental disseminated candidiasis: lack of correlation between in vitro and in vivo observations with amphotericin B and rifampin. | Rev Infect Dis | 1983 | https://conductscience.org/library/papers/6356285 | PubMed |
| 20 | 3973417 | Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. | J Infect Dis | 1985 | https://conductscience.org/library/papers/3973417 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 29370698 | Discovery of a Novel Dibromoquinoline Compound Exhibiting Potent Antifungal and Antivirulence Activity That Targets Metal Ion Homeostasis. | ACS Infect Dis | 2018 | https://conductscience.org/library/papers/29370698 | PubMed |
| 15015031 | Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy. | Eur J Clin Microbiol Infect Dis | 2004 | https://conductscience.org/library/papers/15015031 | PubMed |
| 9350751 | Comparison of a photometric method with standardized methods of antifungal susceptibility testing of yeasts. | J Clin Microbiol | 1997 | https://conductscience.org/library/papers/9350751 | PubMed |
| 8269392 | Antifungal susceptibility testing. | Clin Microbiol Rev | 1993 | https://conductscience.org/library/papers/8269392 | PubMed |
| 7695274 | New in vitro assay based on glucose consumption for determining intraconazole and amphotericin B activities against Aspergillus fumigatus. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/7695274 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3729367
GET https://conductscience.org/api/papers/v1/3729367/references?page=2